JPS5824559A - 新規スルフイミン化合物 - Google Patents

新規スルフイミン化合物

Info

Publication number
JPS5824559A
JPS5824559A JP57128814A JP12881482A JPS5824559A JP S5824559 A JPS5824559 A JP S5824559A JP 57128814 A JP57128814 A JP 57128814A JP 12881482 A JP12881482 A JP 12881482A JP S5824559 A JPS5824559 A JP S5824559A
Authority
JP
Japan
Prior art keywords
group
carbon atoms
general formula
radicals
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57128814A
Other languages
English (en)
Japanese (ja)
Inventor
エリツヒ・ミユ−ラ−
ヨゼフ・ニツクル
ベルトルド・ナ−ル
ヨゼフ・ロツクス
バルタ−・ハ−ルマン
ヨハネス・マクシミリアン・ヴイ−ゼンバ−ガ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of JPS5824559A publication Critical patent/JPS5824559A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP57128814A 1981-07-25 1982-07-23 新規スルフイミン化合物 Pending JPS5824559A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE31294448 1981-07-25
DE19813129444 DE3129444A1 (de) 1981-07-25 1981-07-25 "sulfoximine, deren herstellung und diese verbindungen enthaltende arzneimittel"
DE31429041 1981-10-29

Publications (1)

Publication Number Publication Date
JPS5824559A true JPS5824559A (ja) 1983-02-14

Family

ID=6137766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57128814A Pending JPS5824559A (ja) 1981-07-25 1982-07-23 新規スルフイミン化合物

Country Status (19)

Country Link
JP (1) JPS5824559A (hu)
KR (1) KR840000491A (hu)
AR (1) AR230745A1 (hu)
AU (1) AU556082B2 (hu)
CA (1) CA1175430A (hu)
CS (1) CS236488B2 (hu)
DD (1) DD202871A5 (hu)
DE (2) DE3129444A1 (hu)
DK (1) DK329582A (hu)
ES (4) ES514275A0 (hu)
FI (1) FI822550L (hu)
GR (1) GR76181B (hu)
HU (1) HU188188B (hu)
NO (1) NO822255L (hu)
PL (1) PL137725B1 (hu)
PT (1) PT75297A (hu)
SU (1) SU1158041A3 (hu)
YU (1) YU158182A (hu)
ZA (1) ZA825273B (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011509952A (ja) * 2008-01-17 2011-03-31 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 免疫調節薬としてのスルホキシミン置換キナゾリン誘導体、それらの調製及び医薬品としての使用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011509952A (ja) * 2008-01-17 2011-03-31 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 免疫調節薬としてのスルホキシミン置換キナゾリン誘導体、それらの調製及び医薬品としての使用

Also Published As

Publication number Publication date
PT75297A (fr) 1982-08-01
GR76181B (hu) 1984-08-03
KR840000491A (ko) 1984-02-22
DD202871A5 (de) 1983-10-05
DE3129444A1 (de) 1983-02-10
ZA825273B (en) 1984-03-28
PL237600A1 (en) 1983-03-28
NO822255L (no) 1983-01-26
AU8637882A (en) 1983-04-14
DE3246980A1 (de) 1984-06-20
ES8305333A1 (es) 1983-04-01
ES518826A0 (es) 1983-10-16
ES8400412A1 (es) 1983-10-16
FI822550A0 (fi) 1982-07-20
SU1158041A3 (ru) 1985-05-23
AR230745A1 (es) 1984-06-29
FI822550L (fi) 1983-01-26
ES8400411A1 (es) 1983-10-16
PL137725B1 (en) 1986-07-31
ES518828A0 (es) 1983-10-16
ES518827A0 (es) 1983-10-16
AU556082B2 (en) 1986-10-23
HU188188B (en) 1986-03-28
DK329582A (da) 1983-01-26
ES8400410A1 (es) 1983-10-16
CS236488B2 (en) 1985-05-15
YU158182A (en) 1984-08-31
ES514275A0 (es) 1983-04-01
CA1175430A (en) 1984-10-02

Similar Documents

Publication Publication Date Title
TWI675026B (zh) 稠環衍生物、其製備方法、中間體、藥物組合物及應用
US4376771A (en) 6-(p-Acylaminophenyl)-4,5-dihydropyridaz-3-ones and therapeutic agents containing said compounds
IL129409A (en) 1-Phenylpyrazole compounds and pharmaceutical preparations containing them
WO2014044113A1 (zh) 吡唑并[3,4-c]吡啶类衍生物、其制备方法及其在医药上的应用
JP4805166B2 (ja) アロイルフランおよびアロイルチオフェン
KR102492715B1 (ko) 모노시클릭 헤테로아릴 치환된 화합물
CN107163044A (zh) 一类具有蛋白酶修饰活性的萘乙二酮化合物及其衍生物
JPS6236382A (ja) チエノピリドン治療薬及びその製法
WO2012078519A2 (en) 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2
WO2017107262A1 (zh) 基于萜类衍生物的par-1抑制剂及其制备方法和在治疗血栓性疾病中的用途
JPS58216186A (ja) グアニジノチアゾ−ル誘導体、それらの製造法およびそれらの薬剤としての用途
FI79704C (fi) Foerfarande foer framstaellning av benzoxazin-2-oner.
US4330550A (en) Oxoimidazolinealkanoic acids and their salts and esters, their preparation and pharmaceutical compositions containing them
JPS5824559A (ja) 新規スルフイミン化合物
FI75806B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3,3-dimetylsubstituerad indoliner.
JP2010531353A5 (hu)
EP0071150B1 (de) Sulfimine, deren Salze und deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
JPS59104378A (ja) カルボスチリル誘導体
JPH0156067B2 (hu)
JPH04139185A (ja) ピラゾロピリジン誘導体
JPH03135957A (ja) 置換(キノリン‐2‐イル‐メトキシ)フェニル‐チオ尿素類
JPH02275870A (ja) 1,4―チアジン誘導体
JPS61212552A (ja) 新規スルホニルアミノエチル化合物
DE3142904A1 (de) Arzneimittel zur vermeidung von tumormetasierung
SI8010849A8 (sl) Postopek za pridobivanje 3-(metiltio, metilsulfinil ali metilsulfonil)-4-kinolonov